Recently, it has been discovered that SCOP suppresses inflammatory responses by inhibiting PI3K‐Akt signalling in chondrocytes, suggesting that SCOP may be a therapeutic compound in degenerative and bone diseases such as osteoarthritis.11 This evidence concerns the gene PHLPP1 and osteoarthritis.